Concurrent whole brain radiotherapy and bortezomib for brain metastasis

BACKGROUND: Survival of patients with brain metastasis particularly from historically more radio-resistant malignancies remains dismal. A phase I study of concurrent bortezomib and whole brain radiotherapy was conducted to determine the tolerance and safety of this approach in patients with previous...

Descripción completa

Detalles Bibliográficos
Autores principales: Lao, Christopher D, Friedman, Judah, Tsien, Christina I, Normolle, Daniel P, Chapman, Christopher, Cao, Yue, Lee, Oliver, Schipper, Matt, Van Poznak, Catherine, Hamstra, Daniel, Lawrence, Theodore, Hayman, James, Redman, Bruce G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765365/
https://www.ncbi.nlm.nih.gov/pubmed/23965287
http://dx.doi.org/10.1186/1748-717X-8-204

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765365/
https://www.ncbi.nlm.nih.gov/pubmed/23965287
http://dx.doi.org/10.1186/1748-717X-8-204

Ejemplares similares